Elanco Animal Health Inc
NYSE:ELAN

Watchlist Manager
Elanco Animal Health Inc Logo
Elanco Animal Health Inc
NYSE:ELAN
Watchlist
Price: 13.13 USD -1.94% Market Closed
Market Cap: 6.5B USD
Have any thoughts about
Elanco Animal Health Inc?
Write Note

Wall Street
Price Targets

ELAN Price Targets Summary
Elanco Animal Health Inc

Wall Street analysts forecast ELAN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ELAN is 19.1 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.

Lowest
Price Target
15.15 USD
15% Upside
Average
Price Target
19.1 USD
45% Upside
Highest
Price Target
22.05 USD
68% Upside

ELAN Last Price Targets
Elanco Animal Health Inc

The latest public price target was made on Sep 23, 2024 by Balaji Prasad from Barclays , who expects ELAN stock to rise by 68% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Balaji Prasad
Barclays
22 USD
Upside 68%
2 months ago
Sep 23, 2024
Elanco price target raised to $22 from $21 at Barclays
TheFly
David Westenberg
Piper Sandler
16 USD
Upside 22%
4 months ago
Jul 1, 2024
Elanco price target lowered to $16 from $19 at Piper Sandler
TheFly
David Westenberg
Piper Sandler
19 USD
Upside 45%
6 months ago
May 13, 2024
Elanco Animal Health (ELAN) PT Raised to $19 at Piper Sandler
StreetInsider
David Westenberg
Piper Sandler
18 USD
Upside 37%
8 months ago
Mar 12, 2024
Elanco Animal Health (ELAN) PT Raised to $18 at Piper Sandler
StreetInsider
Balaji Prasad
Barclays
Price Target 22 USD
Upside/Downside 68%
View Source
David Westenberg
Piper Sandler
Price Target 16 USD
Upside/Downside 22%
View Source
David Westenberg
Piper Sandler
Price Target 19 USD
Upside/Downside 45%
View Source
David Westenberg
Piper Sandler
Price Target 18 USD
Upside/Downside 37%
View Source
Elanco Animal Health Inc Competitors:
Price Targets
DMP
Dermapharm Holding SE
30% Upside
CONCORDBIO
Concord Biotech Ltd
2% Downside
MDWD
Mediwound Ltd
80% Upside
4578
Otsuka Holdings Co Ltd
5% Upside
PHAT
Phathom Pharmaceuticals Inc
188% Upside
170900
Dong-A ST Co Ltd
49% Upside
ANCR
Animalcare Group PLC
26% Upside
605116
Aurisco Pharmaceutical Co Ltd
49% Upside

Revenue
Forecast

Revenue Estimate
Elanco Animal Health Inc

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's revenue is 5%. The projected CAGR for the next 3 years is 3%.

5%
Past Growth
3%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Elanco Animal Health Inc

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's operating income is 67%. The projected CAGR for the next 3 years is 39%.

67%
Past Growth
39%
Estimated Growth
Estimates Accuracy
-55%
Average Miss

Net Income
Forecast

Net Income Estimate
Elanco Animal Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ELAN's stock price target?
Price Target
19.1 USD

According to Wall Street analysts, the average 1-year price target for ELAN is 19.1 USD with a low forecast of 15.15 USD and a high forecast of 22.05 USD.

What is Elanco Animal Health Inc's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's revenue is 5%. The projected CAGR for the next 3 years is 3%.

What is Elanco Animal Health Inc's Operating Income forecast?
Projected CAGR
39%

For the last 8 years the compound annual growth rate for Elanco Animal Health Inc's operating income is 67%. The projected CAGR for the next 3 years is 39%.

Back to Top